Grifols introduces KIRO Oncology, a next-generation robotic system for automated sterile compounding of hazardous drugs. It is a self-cleaning system featuring two robotic arms, a Lean design, and the ability to use syringes, final containers, and drugs from various manufacturers. The system optimizes safety, improves accuracy, and closely monitors the preparation of IV solutions for oncology patients while protecting technicians against the risks associated with the handling of hazardous substances. KIRO Oncology helps maintain compliance with USP regulations by standardizing the process, thereby reducing errors and the risk of contamination in the preparation of hazardous admixtures.